Nancy Harrison, MD
Rheumatology · Hattiesburg, MSNPI 1457763336
Payments from drug & device makers
Across 849 payments — averaging $18.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$4K
- AbbVie$3K
- UCB, Inc.$1K
- Novartis$1K
- Johnson & Johnson$865
- GSK$846
- plus $4K from 21 others
What the payments were for
- Food & beverage$15,67899%
- Education$2151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 217 | $4,417 |
| AbbVie | 179 | $3,056 |
| UCB, Inc. | 75 | $1,285 |
| Novartis | 46 | $1,004 |
| Johnson & Johnson | 50 | $865 |
| GSK | 46 | $846 |
| AstraZeneca(2 entities) | 37 | $634 |
| Genentech USA, Inc. | 29 | $589 |
| Pfizer | 35 | $560 |
| Octapharma USA, Inc. | 19 | $376 |
| Radius Health, Inc. | 13 | $293 |
| E.r. Squibb & Sons, L.L.C. | 16 | $261 |
| Boehringer Ingelheim | 14 | $250 |
| Aurinia Pharma U.S., Inc. | 13 | $246 |
| Sanofi | 11 | $243 |
| Fresenius Kabi USA, LLC | 13 | $242 |
| Lilly USA, LLC | 11 | $191 |
| Regeneron Healthcare Solutions, Inc. | 5 | $144 |
| ANI Pharmaceuticals, Inc. | 6 | $103 |
| Sobi, Inc | 5 | $95 |
| Mallinckrodt Hospital Products Inc. | 3 | $66 |
| Tonix Medicines, Inc. | 1 | $28 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $28 |
| Bristol Myers Squibb | 1 | $23 |
| Celltrion USA Inc. | 1 | $17 |
| Sandoz | 1 | $16 |
| Abbott | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Enbrel$331
How this compares
$15,893 in reported general payments places this provider in the 65th percentile of 44 rheumatology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 41 | $300,573 |
| Enbrel SureclickEtanercept | 22 | $212,634 |
| Cosentyx Sensoready PenSecukinumab | 14 | $127,893 |
| Enbrel MiniEtanercept | 13 | $94,933 |
| Hydroxychloroquine Sulfate | 116 | $6,208 |
| MethotrexateMethotrexate Sodium | 253 | $5,003 |
| Celecoxib | 119 | $4,631 |
| Diclofenac Sodium | 167 | $2,828 |
| Duloxetine Hcl | 116 | $2,475 |
| Leflunomide | 36 | $2,120 |
| Azathioprine | 30 | $1,781 |
| Gabapentin | 124 | $1,739 |
| Colchicine | 20 | $1,271 |
| Prednisone | 268 | $1,212 |
| Pilocarpine Hcl | 13 | $1,039 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Hattiesburg
- David WeissHattiesburg$597K
- Muhammad IjazHattiesburg$19K
- Imad BitarHattiesburg$18K
- Portia HarrisHattiesburg$4K
- Chris BensonHattiesburg$231
- Vikas MajithiaJackson$1.4M
- Kirk EddlemanOxford$576K
- Charles KingTupelo$404K
- Jason TaylorMadison$173K
- Matthew CarrollKeesler Afb$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.